Page last updated: 2024-08-22

glucosamine and Bowel Diseases, Inflammatory

glucosamine has been researched along with Bowel Diseases, Inflammatory in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (33.33)	18.2507
2000's	2 (22.22)	29.6817
2010's	1 (11.11)	24.3611
2020's	3 (33.33)	2.80

Authors

Authors	Studies
di Michele, F	1
Corpetti, C; Del Re, A; Esposito, G; Franzin, SB; Palenca, I; Pesce, M; Rurgo, S; Sarnelli, G; Seguella, L; Steardo, L	1
Faith, JJ; Fan, TJ; Goeser, L; Hansen, JJ; Lu, K	1
Lie, D; Najm, W	1
Kouroumalis, EA; Koutroubakis, IE; Malliaraki, N; Messaritakis, I; Oustamanolakis, P; Sfiridaki, A	1
Bielefeldt-Ohmann, H; Correia, Jda S; Crane, RT; Fling, SP; Fort, MM; Hershberg, RM; Jeffery, E; Johnson, DA; Mozaffarian, A; Persing, DH; Probst, P; Stöver, AG; Ulevitch, RJ	1
Aasakura, H; Honma, T; Sugimura, K	1
Russell, AL	1
McCarty, MF	1

Reviews

1 review(s) available for glucosamine and Bowel Diseases, Inflammatory

Article	Year
[Emergency drug therapy of non-specific inflammatory bowel diseases--progress on diagnosis and therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Nov-10, Volume: 84, Issue:11 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Drug Combinations; Emergencies; Glucosamine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Prednisolone; Sulfasalazine	1995

Article

Year

[Emergency drug therapy of non-specific inflammatory bowel diseases--progress on diagnosis and therapy].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Nov-10, Volume: 84, Issue:11

Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Drug Combinations; Emergencies; Glucosamine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Prednisolone; Sulfasalazine

1995

Other Studies

8 other study(ies) available for glucosamine and Bowel Diseases, Inflammatory

Article	Year
Asthma Exacerbation Associated with Glucosamine Supplement: An Association Between Airways Disorders and Inflammatory Bowel Diseases? Current medicinal chemistry, 2022, Volume: 29, Issue:35 Topics: Asthma; Dietary Supplements; Glucosamine; Humans; Inflammatory Bowel Diseases	2022
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism. Biomolecules, 2022, 08-22, Volume: 12, Issue:8 Topics: Animals; Colitis; Dinitrofluorobenzene; Dogs; Glucosamine; Inflammation; Inflammatory Bowel Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; PPAR alpha; Toll-Like Receptor 4	2022
Enterococcus faecalis Glucosamine Metabolism Exacerbates Experimental Colitis. Cellular and molecular gastroenterology and hepatology, 2021, Volume: 12, Issue:4 Topics: Animals; Biomarkers; Colitis; Disease Models, Animal; Disease Progression; Disease Susceptibility; Dysbiosis; Enterococcus faecalis; Gastrointestinal Microbiome; Gene Expression Regulation, Bacterial; Glucosamine; Host Microbial Interactions; Inflammatory Bowel Diseases; Metagenome; Metagenomics; Mice; Mice, Knockout	2021
Dietary supplements commonly used for prevention. Primary care, 2008, Volume: 35, Issue:4 Topics: Camellia sinensis; Cardiovascular Diseases; Carotenoids; Chondroitin; Cimicifuga; Dietary Supplements; Echinacea; Fish Oils; Flax; Glucosamine; Humans; Inflammatory Bowel Diseases; Lutein; Lycopene; Neoplasms; Plant Preparations; Primary Health Care; Primary Prevention; Probiotics; Silybum marianum; United States; Vaccinium macrocarpon; Zingiber officinale	2008
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:3 Topics: Adolescent; Adult; Aged; Anemia; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Azathioprine; C-Reactive Protein; Cross-Sectional Studies; Drug Combinations; Enzyme Inhibitors; Female; Gastrointestinal Agents; Glucosamine; Hepcidins; Humans; Inflammatory Bowel Diseases; Iron; Male; Methotrexate; Middle Aged; Protein Precursors; Smoking; Sulfasalazine; Young Adult	2011
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. Journal of immunology (Baltimore, Md. : 1950), 2005, May-15, Volume: 174, Issue:10 Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caproates; Cells, Cultured; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Glucosamine; HeLa Cells; Humans; Inflammatory Bowel Diseases; Lipid A; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Knockout; Monocytes; Receptors, Immunologic; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2005
Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift. Medical hypotheses, 1998, Volume: 51, Issue:4 Topics: Animals; Glucosamine; Humans; Inflammatory Bowel Diseases; Osteoarthritis; Wound Healing	1998
Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier--implications for use of glucosamine in inflammatory disorders. Medical hypotheses, 1998, Volume: 51, Issue:1 Topics: Animals; Endothelium, Vascular; Glucosamine; Heparitin Sulfate; Humans; Inflammation; Inflammatory Bowel Diseases; Leukocytes; Models, Biological	1998